09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

p-NITROSODIPHENYLAMINE<br />

CAS No: 156-10-5<br />

I. PHYSICAL AND CHEMICAL PROPERTIES (From HSDB, 1994)<br />

Molecular weight 198.24<br />

Boiling point<br />

not available<br />

Melting point 144-145 °C<br />

Vapor pressure<br />

not available<br />

Air concentration conversion 1 ppm = 8.1 mg/m 3<br />

II.<br />

HEALTH ASSESSMENT VALUES<br />

Unit Risk Factor: 6.3 E-6 (µg/m 3 ) -1<br />

Slope Factor: 2.2 E-2 (mg/kg-day) -1<br />

[Male rat liver tumor data (NCI, 1979), contained in Gold et al. (1984) database, expedited<br />

Proposition 65 methodology (Cal/EPA, 1992), with cross-route extrapolation.]<br />

III.<br />

CARCINOGENIC EFFECTS<br />

Human Studies<br />

No studies on the potential carcinogenic effects of p-nitrosodiphenylamine in humans are known to<br />

exist.<br />

Animal Studies<br />

Male and female Fischer 344 rats and B6C3F 1 mice were fed diets containing technical grade p-<br />

nitrosodiphenylamine (73% active material, 25% water, unspecified impurities). Rats were fed diets<br />

containing 2500 or 5000 mg/kg diet p-nitrosodiphenylamine for 78 weeks, followed by a 27 week<br />

observation period. Mice were fed diets containing either 5000 mg/kg diet p-nitrosodiphenylamine for<br />

40 weeks, then 2500 mg/kg diet for 17 weeks, or 10000 mg/kg diet for 40 weeks, followed by control<br />

diet for 7 weeks, then 5000 mg/kg for 10 weeks. Both dose groups were then maintained on control<br />

diet for an additional 35 weeks. Treatment groups consisted of 50 animals/sex/species/group; matched<br />

control groups consisted of 20 animals/sex/species and were kept under observation for 105 and 92<br />

weeks for rats and mice, respectively. Rat survival was 90, 86 and 92% for males and 85, 84 and 92%<br />

for females in the control, low-dose and high-dose groups, respectively. Mouse survival was 85, 88<br />

and 60% for males and 90, 84 and 52% for females in the control, low-dose and high-dose groups,<br />

respectively. Significant increases in the incidence of liver tumors (neoplastic nodules, hepatocellular<br />

adenomas and carcinomas) was noted in treated male mice and rats. Tumor incidence data is listed in<br />

Table 1.<br />

413

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!